| Catalog# | CAS NO. | Abbreviation | Product name | M.F. | M.W. |
| 8304001 | 1000164-43-1 | Fmoc-Ser(tbu)-Ser(PsiMe,MePro)-OH | (4S)-3-(Fmoc-Ser(tBu))-2,2-dimethyl-oxazolidine-4-carboxylic acid, | C28H34N2O7 | 510.59 |
| 8304002 | 878797-09-2 | Fmoc-Tyr(tbu)-Ser(PsiMe,MePro)-OH | |||
| 8304003 | Fmoc-D-Ser(tbu)-D-Ser(PsiMe,MePro)-OH | ||||
| 8304004 | 252554-79-3 | Fmoc-Ala-Thr(Psi Me,Me pro)-OH | (4s,5r)-3-(fmoc-ala)-2,2,5-trimethyloxazolidine-4-carboxylic acid, | C25H28N2O6 | 452.5 |
| 8304005 | 1262308-49-5 | Fmoc-Gly-Thr(Psi Me,Me Pro)-OH | (4S,5R)-3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid, | C24H26N2O6 | 438.47 |
| 8304006 | Fmoc-Ser(tbu)-Cys(PsiMe,MePro)-OH | (R)-3-(Fmoc-Ser(tBu))-2,2-dimethylthiazolidine-4-carboxylic acid, | C28H34N2O6S | 526.64 | |
| 8304007 | 873842-17-2 | Fmoc-Gly-Cys(PsiMe,MePro)-OH | 4-thiazolidinecarboxylic acid,3-[[[(9h-fluoren-9-ylmethoxy)carbonyl]amino]acetyl]-2,2-dimethyl-,(4r)- | C23H24N2O5S | 440.51 |
| 8304008 | Fmoc-Gly-Ser(ψ proMe, Me)-OH | ||||
| 8304009 | 920519-32-0 | Fmoc-Asp(OtBu)-Thr(ΨMe,Mepro)-OH | C30H36N2O8 | 552.62 | |
| 8304010 | Fmoc-Phe-Thr(ΨMe,Mepro) -OH | ||||
| 8304011 | Fmoc-D-Ser(tbu)-D-Ser(PsiMe,MePro)-OH | (4R)-3-(Fmoc-D-Ser(tBu))-2,2-dimethyl-oxazolidine-4-carboxylic acid,(R)-3-(N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-D-seryl)-2,2-dimethyloxazolidine-4-carboxylic acid, | C28H34N2O7 | 510.59 | |
| Catalog# | CAS NO. | Abbreviation | Product name | M.F. | M.W. |
| 8305001 | 169396-92-3 | Fmoc-PNA-T-OH | Fmoc-T-aeg-OH,Fmoc-PNA-Thymine-OH, | C26H26N4O7 | 506.51 |
| 8305002 | 186046-82-2 | Fmoc-PNA-A(Bhoc)-OH | Fmoc-A(Bhoc)-aeg-OH,Fmoc-PNA-Adenine(Bhoc)-OH | C40H35N7O7 | 725.75 |
| 8305003 | 186046-81-1 | Fmoc-PNA-C(Bhoc)-OH | Fmoc-C(Bhoc)-aeg-OH,Fmoc-PNA-Cytosine(Bhoc)-OH | C39H35N5O8 | 701.72 |
| 8305004 | 186046-83-3 | Fmoc-PNA-G(Bhoc)-OH | Fmoc-G(Bhoc)-aeg-OH,Fmoc-PNA-Guanine(Bhoc)-OH | C40H35N7O8 | 741.75 |
| 8305102 | 20924-05-4 | T-CH2COOH | Thymine-1-acetic acid, (5-Methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetic acid, 2-[5-METHYL-2,4-DIOXO-3,4-DIHYDRO-1(2H)-PYRIMIDINYL]ACETIC ACID, 2-(5-methyl-2,4-dioxo-1,3-dihydropyrimidinyl)acetic acid, | C7H8N2O4 | 184.15 |
| 8305103 | Fmoc-AEG-OBn | benzyl (2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)glycinate, | C26H26N2O4 | 430.5 | |
| 8305104 | 186046-80-0 | A(Bhoc)-CH2COOH | 2-[6-(benzhydryloxycarbonylamino)purin-9-yl]acetic acid,(6-benzhydryloxycarbonylamino-purin-9-yl)-acetic acid, (6-Benzhydryloxycarbonylaminopurin-9-yl)acetic acid, 2-(6-(((Benzhydryloxy)carbonyl)amino)-9H-purin-9-yl)acetic acid, | C21H17N5O4 | 403.39 |
| 8305105 | 186046-78-6 | C(Bhoc)-CH2COOH | (4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid, (4-benzhydryloxycarbonylamino-2-oxo-2h-pyrimidin-1-yl)-acetic acid, 2-(4-(((Benzhydryloxy)carbonyl)amino)-2-oxopyrimidin-1(2H)-yl)acetic acid, | C20H17N3O5 | 379.37 |
| 8305106 | 169287-79-0 | G(Bhoc)-CH3COOH | (2-benzhydryloxycarbonylamino-6-oxo-1,6-dihydro-purin-9-yl)-acetic acid, (2-benzhydryloxycarbonylamino-6-oxo-1,6-dihydropurin-9-yl)acetic acid, 2-(2-(((Benzhydryloxy)carbonyl)amino)-6-oxo-1H-purin-9(6H)-yl)acetic acid, | C21H17N5O5 | 419.39 |
| 8305107 | 141743-15-9 | Boc-AEG(Fmoc)-OH | Fmoc-N-(2-Boc-aminoethyl)glycine,Fmoc-N-(2-Boc-aminoethyl)-Gly-OH,2-[9H-fluoren-9-ylmethoxycarbonyl-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]amino]acetic acid, | C24H28N2O6 | 440.49 |
| 8305108 | 172405-45-7 | Fmoc-AEG-OH | N-[N'-Fmoc-(2'-Aminoethyl)]Glycine,(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)glycine, | C19H20N2O4 | 340.38 |
